Ribavirin, viramidine and adenosine-deaminase-catalysed drug activation: implication for nucleoside prodrug design

J Antimicrob Chemother. 2003 Oct;52(4):543-6. doi: 10.1093/jac/dkg405. Epub 2003 Sep 1.
No abstract available

Publication types

  • Review

MeSH terms

  • Adenosine Deaminase / administration & dosage*
  • Adenosine Deaminase / chemistry
  • Animals
  • Catalysis / drug effects
  • Drug Design
  • Humans
  • Nucleosides / administration & dosage
  • Nucleosides / chemical synthesis
  • Prodrugs / administration & dosage*
  • Prodrugs / chemical synthesis
  • Ribavirin / administration & dosage*
  • Ribavirin / analogs & derivatives*
  • Ribavirin / chemistry

Substances

  • Nucleosides
  • Prodrugs
  • Ribavirin
  • Adenosine Deaminase
  • taribavirin